ERAS
Price
$9.93
Change
-$0.36 (-3.50%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
3.05B
54 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$117.67
Change
-$1.13 (-0.95%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
22.74B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ERAS vs RVMD

Header iconERAS vs RVMD Comparison
Open Charts ERAS vs RVMDBanner chart's image
Erasca
Price$9.93
Change-$0.36 (-3.50%)
Volume$211.6K
Capitalization3.05B
Revolution Medicines
Price$117.67
Change-$1.13 (-0.95%)
Volume$38.37K
Capitalization22.74B
ERAS vs RVMD Comparison Chart in %
ERAS
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ERAS vs. RVMD commentary
Jan 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a Hold and RVMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 24, 2026
Stock price -- (ERAS: $9.96 vs. RVMD: $117.63)
Brand notoriety: ERAS and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 125% vs. RVMD: 71%
Market capitalization -- ERAS: $3.05B vs. RVMD: $22.74B
ERAS [@Biotechnology] is valued at $3.05B. RVMD’s [@Biotechnology] market capitalization is $22.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both ERAS and RVMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • ERAS’s TA Score: 4 bullish, 4 bearish.
  • RVMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ERAS and RVMD are a good buy in the short-term.

Price Growth

ERAS (@Biotechnology) experienced а +3.53% price change this week, while RVMD (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.60%. For the same industry, the average monthly price growth was +4.36%, and the average quarterly price growth was +34.13%.

Reported Earning Dates

ERAS is expected to report earnings on Mar 19, 2026.

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+2.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($22.7B) has a higher market cap than ERAS($3.05B). ERAS YTD gains are higher at: 167.742 vs. RVMD (47.684). ERAS has higher annual earnings (EBITDA): -131.32M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. ERAS (288M). ERAS has less debt than RVMD: ERAS (48.3M) vs RVMD (158M). ERAS (0) and RVMD (0) have equivalent revenues.
ERASRVMDERAS / RVMD
Capitalization3.05B22.7B13%
EBITDA-131.32M-1.02B13%
Gain YTD167.74247.684352%
P/E RatioN/AN/A-
Revenue00-
Total Cash288M1.93B15%
Total Debt48.3M158M31%
FUNDAMENTALS RATINGS
RVMD: Fundamental Ratings
RVMD
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASRVMD
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 19 days ago
87%
Bearish Trend 4 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WTIU11.560.31
+2.77%
MicroSectors™ Energy 3X Leveraged ETN
IDVZ33.390.27
+0.82%
Opal International Div Inc ETF
IFGL23.750.05
+0.21%
iShares International Dev Real Est ETF
PFL8.410.01
+0.18%
PIMCO Income Strategy Fund
NZF12.20-0.07
-0.57%
Nuveen Municipal Credit Income Fund

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with RVMD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
-3.21%
RVMD - ERAS
60%
Loosely correlated
-0.99%
NUVL - ERAS
48%
Loosely correlated
-4.96%
ORIC - ERAS
48%
Loosely correlated
-0.50%
ZNTL - ERAS
45%
Loosely correlated
-9.54%
CRNX - ERAS
44%
Loosely correlated
-3.22%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-0.99%
NUVL - RVMD
62%
Loosely correlated
-4.96%
ERAS - RVMD
61%
Loosely correlated
-3.21%
CGON - RVMD
54%
Loosely correlated
-3.65%
CRNX - RVMD
52%
Loosely correlated
-3.22%
IDYA - RVMD
49%
Loosely correlated
-3.87%
More